CS167902B2 - - Google Patents
Info
- Publication number
- CS167902B2 CS167902B2 CS81470A CS81470A CS167902B2 CS 167902 B2 CS167902 B2 CS 167902B2 CS 81470 A CS81470 A CS 81470A CS 81470 A CS81470 A CS 81470A CS 167902 B2 CS167902 B2 CS 167902B2
- Authority
- CS
- Czechoslovakia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3125569 | 1969-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS167902B2 true CS167902B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-05-28 |
Family
ID=10320364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS81470A CS167902B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1969-06-20 | 1970-06-19 |
Country Status (5)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2575158B1 (fr) * | 1984-12-20 | 1987-10-02 | Pf Medicament | Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central |
| WO1993015052A1 (en) * | 1992-01-28 | 1993-08-05 | Smithkline Beecham Plc | Compounds as calcium channel antagonists |
| US6207662B1 (en) | 1996-08-23 | 2001-03-27 | Neurosearch A/S | Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine D4 receptor antagonists |
| AU9087301A (en) | 2000-09-11 | 2002-03-26 | Sepracor Inc | Ligands for monoamine receptors and transporters, and methods of use thereof |
| US7294637B2 (en) | 2000-09-11 | 2007-11-13 | Sepracor, Inc. | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
| AU2005238296A1 (en) * | 2004-04-30 | 2005-11-10 | Warner-Lambert Company Llc | Substituted morpholine compounds for the treatment of central nervous system disorders |
| AU2007311591B2 (en) | 2006-10-18 | 2010-10-07 | Pfizer Products Inc. | Biaryl ether urea compounds |
| MX2023010937A (es) | 2021-03-18 | 2024-03-25 | Supernus Pharmaceuticals Inc | Derivados de morfolinas sustituidas y usos de estos. |
| US20240336581A1 (en) | 2023-03-27 | 2024-10-10 | Supernus Pharmaceuticals, Inc. | Derivatives of substituted morpholines and uses thereof |
-
1969
- 1969-06-20 GB GB5013069A patent/GB1260886A/en not_active Expired
- 1969-12-16 BR BR21522169A patent/BR6915221D0/pt unknown
-
1970
- 1970-06-06 PL PL18255570A patent/PL92088B1/pl unknown
- 1970-06-19 CS CS81470A patent/CS167902B2/cs unknown
- 1970-06-22 AT AT562170A patent/AT300820B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB1260886A (en) | 1972-01-19 |
| AT300820B (de) | 1972-08-10 |
| BR6915221D0 (pt) | 1973-02-13 |
| PL92088B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-03-31 |